JAK/STAT3 signaling pathway mediates endothelial‑like differentiation of immature dendritic cells
- Authors:
- Published online on: September 25, 2015 https://doi.org/10.3892/ol.2015.3752
- Pages: 3471-3477
-
Copyright: © Jin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Abstract
Introduction
Dendritic cells (DCs) are antigen-presenting cells that are important in the initiation and regulation of immune responses (1–3). DCs present antigenic peptides to initiate primary T-cell responses, and additionally, DCs express costimulatory molecules that drive quiescent T cells into the cell cycle, promoting their differentiation (3,4). Previous studies have demonstrated the expression levels of endothelial (CD31, vWF and CD144) and dendritic precursor (CD205) cell surface markers and the antigen-presenting ability of DCs decrease significantly following their infiltration of tumors (5–8). However, the mechanisms behind these observations remain to be elucidated.
It has been reported previously that conditioned medium from murine Lewis lung carcinoma cells redirects the differentiation of CD34+ progenitor cells away from a DC pathway to an endothelial cell (ECs) fate (9). In addition, DC precursors can transdifferentiate into endothelial-like cells (ELCs) in mouse and human ovarian carcinomas following the addition of vascular endothelial growth factor-A (VEGF-A) and β-defensins (10). Furthermore, tumor-associated DCs incubated with the pro-angiogenic factors VEGF-A and oncostain M can transdifferentiate into ELCs, and this is suggested as an alternative pathway of tumor angiogenesis (11). Additional reports have demonstrated that DC progenitors or immature DCs (iDCs) have the ability to transdifferentiate into ELCs, potentially contributing to vasculogenesis in adult tissues. Therefore, DCs may be crucial to the neovascularization process in a number of physiopathological conditions (12,13).
STAT3 (signal transducer and activator of transcription 3) is activated by JAK (janus tyrosine kinase)-mediated tyrosine phosphorylation following receptor-ligand binding. The JAK/STAT3 signaling pathway regulates cell growth, proliferation, differentiation and apoptosis, and is important in the signal transduction of cytokines and growth factors (14,15). However, the function of the JAK/STAT3 signaling pathway on endothelial-like differentiation (ELD) remains to be elucidated.
Esophageal cancer (EC) is the sixth leading cause of cancer-associated mortality and the eighth most frequently diagnosed cancer worldwide (16). China has one of the highest incidences of esophageal cancer, with an estimate of >220,000 new detected cases and 200,000 mortalities every year (17). The predominant form of esophageal cancer is esophageal squamous cell carcinoma (ESCC), characterized by a poor prognosis and high invasiveness (18). It has been reported previously that tumor-associated factors derived from homogenates of EC9706 human ESCC cells may induce iDCs to differentiate into ELCs (19). However, the impact of different tumor-differentiated degree ESCC on the ELD of iDCs is unclear, and the function of JAK/STAT3 signal in this process is unknown. In the present study, we investigated the effect on ELD of iDCs using cell culture supernatant obtained from the KYSE450 (high differentiation) and KYSE70 (poor differentiation) ESCC cell line, and demonstrated the role of JAK/STAT3 signal pathway therein.
Materials and methods
Preparation of KYSE450 and KYSE70 cell line supernatant
The KYSE450 and KYSE70 ESCC cell lines (Nanjing KeyGEN Biotech. Co., Ltd. (Nanjing, China) were cultured in RPMI-1640 medium supplemented with 10% fetal calf serum. The cells were replenished with fresh medium at 60–80% confluency. The cells were used at passage 6–9. The supernatant was collected and filtered following 24 h of incubation, and stored at −20°C.
Induction of ELCs from immature DCs
Peripheral blood mononuclear cells (PBMCs) were harvested from healthy adult volunteers (who provided written informed consent) and isolated using density gradient centrifugation with Ficoll-Paque. The purified cells were seeded in 12-well plates (11). Adherent cells (monocytes) were induced towards a DC fate using rhGM-CSF (100 ng/ml; Amoytop Biotech, Xiamen, China) and rhIL-4, (5 ng/ml; PeproTech China, Suzhou, China). 40% KYSE450 supernatant or 40% KYSE70 supernatant and 60% DCs medium was added at the end of day 2. Following 7 days of induction (day 9), the cells were harvested for use in experiments. As for controls, adherent cells (monocytes) were similarly induced towards DC fate using rhGM-CSF and rhIL-4. They were mature DCs when harvested for use in experiments.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis
The total RNA was extracted with Trizol (Invitrogen), and converted to cDNA according to the protocol of the one-step RT-PCR kit (TaKaRa). The sequences for the oligo-nucleotide primer pairs are as follows: GAPDH, F 5′-GAA GGC TGG GGC TCA TTT-3′ and R 5′-GAG GAG GCA TTG CTG ATG AT-3′; VEGF, F 5′-CCT CCG AAA CCA TGA ACT TT-3′ and R 5′-CCA CCT CGA TGA TTC TGC-3′; IL6, F 5′-TAG TGA GGA ACA AGC CAG AGC-3′ and R 5′-TGG CAT TTG TGG TTG GGT CA-3′; JAK2, F 5′-AGA ATG TCT TGG GAT GGC AG-3′ and R 5′-TGA TAG TCT TGG ATC TTT GCT CG-3′; STAT3, F 5′-TGC TTC CCT GAT TGT GAC TG-3′ and R 5′-CTG ACA GAT GTT GGA GAT CACC-3′; CD144, F 5′-AAA CAC CTC ACT TCC CCA TC-3′ and R 5′-ACC TTG CCC ACA TAT TCT CC-3′; and vWF, F 5′-ATG AGT ATG AGT GTG CCT GC-3′ and R 5′-GTA GAT GGT GCT TCG GTGG-3′. The PCR conditions used were: 95°C for 10 min, 40 × (95°C for 10 sec + 60°C for 30 sec). Each sample was run in triplicate. Analysis of the RT-qPCR data was performed using Applied Biosystems 7500 Fast Real-Time PCR System, v2.0.5 (Applied Biosystems Life Technologies, Foster City, CA, USA).
Immunofluorescence
Control DCs, the KYSE450 cell group (induced by KYSE450 cell supernatant) and the KYSE70 cell group (induced by KYSE70 cell supernatant) were seeded in 12-well plates and incubated for 24 h, then fixed with 4% paraformaldehyde for 30 min. Antibodies were diluted in BSA-PBS (cat no. A8010; Solarbio, Beijing, China). A rabbit anti-human von Willebrand factor (vWF) antibody (1:100; cat no. sc-73268; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) and a Cy3-conjugated goat anti-rabbit IgG secondary antibody were used to detect vWF expression and localization in the three cell groups. To visualize cluster of differentiation 144 (CD144), a rabbit anti-human CD144 antibody (1:200; cat no. 2500; CST Biological Reagents Company Ltd., Shanghai, China) and a 555-conjugated goat anti-rabbit secondary antibody were used. The anti-p-JAK2 (Tyr 1007/Tyr 1008) primary antibody (1:100; cat no. cc-16566-R; Santa Cruz Biotechnology, Inc.) and a 555-conjugated goat anti-rabbit secondary antibody (cat no. P0178-1; Beyotime Institute of Biotechnology, Shanghai, China) were used to detect phosphorylated JAK2. The p-STAT3 (B-7) primary antibody (1:100; cat no. sc-8059; Santa Cruz Biotechnology, Inc.) and a 488-conjugated goat anti-mouse IgG antibody (cat no. P0188-1; Beyotime Institute of Biotechnology) were used to detect phosphorylated STAT3. Cells with fluorescent particles in the cytoplasm were counted as positive expression.
Di1-labeled acetylated low-density lipoprotein (LDL) uptake assay
Control DCs and the KYSE450 and KYSE70 cell groups were seeded in 96-well plates. Following incubation for 36 h, Di1-labeled acetylated-LDL (10 µg/ml; Biomedical Technologies, Stoughton, MA, USA) was added to each well, and all the groups were further incubated at 37°C for another 4 h. The medium containing Dil-Ac-LDL was removed and all the cell samples were washed three times with phosphate-buffered saline and then observed using a IX2-IL100 fluorescence microscope (Olympus Corporation).
Statistical analysis
Data were presented as the mean ± standard deviation (SD), taken from at least three separate experiments and analyzed using one-way analysis of variance. A statistically significant difference was defined as P<0.05.
Results
Changes in iDC morphology during the ELD of iDCs, induced by KYSE450 and KYSE70 supernatant
Immature DCs induced by KYSE450 or KYSE70 supernatant for 4 days appeared round, with a similar form to control DCs. However, following induction of 8 days, the KYSE450 group cells exhibited a fusiform shape, and a number of cells from the KYSE70 group was arranged in cord-like structures, a typical appearance of ECs (Fig. 1).
Protein and mRNA expression of the EC markers vWF and CD144 were detected by immunofluorescence and RT-qPCR
The protein expression levels of EC markers were significantly increased in cells induced by KYSE450 or KYSE70 supernatant, compared with the control DCs (n=4, P<0.001). The immunostaining intensity of the two EC markers was greater in the poorly differentiated ESCC group (KYSE70) compared with the highly differentiated group (KYSE450; Fig. 2A). RT-qPCR analysis demonstrated enhanced expression of vWF and CD144 mRNA in the KYSE450 and KYSE70 groups compared to the control DCs (n=3, P<0.01, P<0.001). Furthermore, the mRNA expression levels of vWF and CD144 in the KYSE70 group were enhanced significantly in comparison to the KYSE450 group (Fig. 2B; n=3, P<0.001). The uptake of Dil-Ac-LDL is considered to be a characteristic function of ECs, although this is performed by other cell types, such as macrophages and monocytes (20,21). Previously, we demonstrated that PBMCs had a weak uptake of Dil-Ac-LDL (19). By contrast, in the current study, the cells induced by KYSE450 or KYSE70 supernatant exhibited a strong uptake of Dil-Ac-LDL compared to the control DCs (n=4, P<0.001). Additionally, the KYSE70 group cells demonstrated a stronger uptake compared to the KYSE450 group (Fig. 2C; n=4, P<0.001). The above results demonstrated that iDCs induced by KYSE450 and KYSE70 supernatant differentiate towards an EC phenotype, and the KYSE70 supernatant induced a greater effect during this transition.
KYSE450 and KYSE70 supernatants induce ELD and activate the JAK/STAT3 signaling pathway in iDCs
During the process of the ELD of iDC, JAK/STAT3 upregulation at the mRNA level was detected by RT-qPCR. The results showed that the mRNA expression levels of JAK and STAT3 increased in the KYSE450 and KYSE70 groups in comparison to the control DCs (Fig. 3A; P<0.05, P<0.01, P<0.001). Furthermore, the KYSE70 group exhibited slightly increased mRNA levels of JAK and STAT3 compared with the KYSE450 group, however this difference was not statistically significant (n=3, P=0.054, P=0.617, respectively). The mRNA expression levels of VEGF-A and IL-6, cytokines downstream of JAK/STAT3 signaling were determined. VEGF-A and IL-6 mRNA levels increased significantly in the KYSE450 and KYSE70 groups compared to the control DCs (P<0.01 for VEGF-A; P<0.001 for IL-6), with a significantly higher level of expression in the KYSE70 group than KYSE450 (Fig. 3A; P<0.01 for VEGF-A; P<0.001 for IL-6). Immunocytochemical analysis demonstrated that JAK and STAT3 were phosphorylated at higher levels in the KYSE450 and KYSE70 groups compared with the control DCs, and the fluorescence intensity in the KYSE70 group was stronger than that in the KYSE450 group (Fig.3B; n=3; P<0.001).
Blocking JAK signaling in iDCs inhibits ELD induced by KYSE450 and KYSE70 supernatants
AG490 (AG) is an inhibitor of JAK. To confirm whether the JAK/STAT3 signaling pathway is involved in the ELD of iDCs, we added 10 µmol AG490 to the KYSE450 and KYSE70 supernatant-treated cells at the end of day 2. Following 8 days of incubation, the mRNA expression levels of vWF and CD144 had significantly decreased in the KYSE450 + AG and KYSE70 + AG groups (Fig. 4A; n=3, P<0.01, P<0.001). Furthermore, the levels of these proteins were significantly decreased, as demonstrated by a reduction in the fluorescence intensity of CD144 and vWF in the KYSE450 + AG and KYSE70+AG groups compared with the control KYSE450 group or KYSE70 group (Fig. 4B; n=3, P<0.001). Additionally, Dil-Ac-LDL uptake was significantly reduced in the KYSE450 and KYSE70 groups incubated with AG490 (Fig. 4C; n=4, P<0.001).
In summary, the results demonstrated the JAK/STAT3 signaling pathway promotes the ELD of iDCs induced by KYSE450 and KYSE70 supernatant, and blocking JAK/STAT3 signaling inhibits the ELD of iDCs.
Discussion
It has previously been reported that incubation of tumor-associated DCs with VEGF and oncostatin M can direct progenitor cell differentiation away from the DC pathway to an ELC fate (11). Furthermore, the tumor microenvironment can induce the ELD of iDCs, but not of mature DCs (22–24). While these previous studies have examined the effect of DC differentiation stage on the transition to ELCs, to the best of our knowledge, there is no previous study that addresses whether the degree of differentiation of tumor cells can influence the ELD of iDCs. In the present study, the impact of the microenvironment produced by ESCC cell line KYSE450 (highly differentiated) and KYSE70 (poorly differentiated) supernatant on the differentiation of iDCs derived from PBMCs, was investigated. The results demonstrate that iDCs induced by the KYSE70 supernatant appeared with fusiform shapes and were arranged into cord-like structures in the KYSE70 and KYSE450 groups. Additionally, the KYSE70- induced group expressed higher levels of the EC markers vWF and CD144, and exhibited stronger Dil-Ac-LDL uptake in comparison with the KYSE450-induced group. These results demonstrate that iDCs can transdifferentiate into ELCs in an ESCC microenvironment, and the supernatant from the poorly differentiated KYSE70 cells had a greater effect on ELD than the supernatant from the highly differentiated KYSE450 cells. This may be due to increased IL-6 and VEGF protein expression in the KYSE70 group, a hypothesis that is supported by our previous findings showing VEGF can induce the ELD of iDCs (22,23). It is known that PBMCs are pluripotent stem cells and can be induced to acquire macrophage, lymphocyte, epithelial, endothelial, neuronal, and hepatocyte phenotypes in the absence of fusion with pre-existing mature tissue cells (25). In the present study, iDCs retained some features of PBMCs, thus, iDCs may differentiate into ELCs in the ESCC microenvironment to varying degrees.
A large number of growth factors, cytokines and vasoactive substances can induce cell differentiation through cellular signal transduction. The JAK/STAT3 signaling pathway is important in cell growth, differentiation, proliferation and apoptosis, and involved in the abnormal differentiation of DCs (26). Previous studies have demonstrated that STAT3 is a key component of diverse signal transduction pathways generated by a large number of cytokines and growth factors, such as IL-6, epidermal growth factor and platelet-derived growth factor. Furthermore, the receptors for these ligands are associated with JAK (27). The results of the current study revealed the JAK/STAT3 signaling pathway was activated during the ELD of iDCs, and the cells in the KYSE70 group exhibited higher levels of p-JAK and p-STAT3, compared with the cells in the KYSE450 group. AG490 is the inhibitor of the JAK/STAT3 signaling pathway, and not only inhibited the activation of JAK signaling, but also inhibited the differentiation of iDCs to ELCs.
In conclusion, the present study demonstrated that iDCs may differentiate into ELCs in response to an ESCC microenvironment, and the degree of differentiation of the ESCC cells may affect the phenotype of the resulting ELC. Poorly differentiated ESCCs had a greater effect on the ELD of iDCs than highly differentiated ESCCs. Additionally, JAK/STAT3 signaling is involved in this process.
Acknowledgements
The present authors would like to thank the healthy peripheral blood donors and the staff in the Open Laboratory of the Basic Medical College of Zhengzhou University. The current study was supported by the National Natural Science Foundation of China (grant no. 81101731), and Science Foundation of Zhengzhou University for the Excellent Young Teacher (grant no. 1421328057), and Henan University of Science and Technology Innovation Talents (grant no. 15HASTIT038).
References
|
Milano F and Krishnadath KK: Electroporation of dendritic cells with autologous total RNA from tumor material. Methods Mol Biol. 1139:87–95. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Benteyn D, Van Nuffel AM, Wilgenhof S and Bonehill A: Single-step antigen loading and maturation of dendritic cells through mRNA electroporation of a tumor-associated antigen and a TriMix of costimulatory molecules. Methods Mol Biol. 1139:3–15. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Aravindaram K, Wang PH, Yin SY and Yang NS: Tumor- associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma. Gene Ther. 21:457–467. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Torchia Giardino ML, Ciaglia E, Masci AM, Vitiello L, Fogli M, la Sala A, Mavilio D and Racioppi L: Dendritic cells/natural killer cross-talk: A novel target for human immunodeficiency virus type-1 protease inhibitors. PLoS One. 5:e110522010. View Article : Google Scholar : PubMed/NCBI | |
|
Benencia F, Sprague L, McGinty J, Pate M and Muccioli M: Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination. J Biomed Biotechnol. 2012:4254762012. View Article : Google Scholar : PubMed/NCBI | |
|
Farren MR, Carlson LM, Netherby CS, Lindner I, Li PK, Gabrilovich DI, Abrams SI and Lee KP: Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCβII abundance. Sci Signal. 7:ra162014. View Article : Google Scholar : PubMed/NCBI | |
|
Wu TC, Xu K, Banchereau R, Marches F, Yu CI, Martinek J, Anguiano E, Pedroza-Gonzalez A, Snipes GJ, O'Shaughnessy J, et al: Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection. Cancer Immunol Res. 2:487–500. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH and Wang RF: Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity. 27:334–348. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Young MR and Cigal M: Tumor skewing of CD34+ cell differentiation from a dendritic cell pathway into endothelial cells. Cancer Immunol Immunother. 55:558–568. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Conejo-Garcia JR, Benencia F, Courreges MC, Kang E, Mohamed-Hadley A, Buckanovich RJ, Holtz DO, Jenkins A, Na H, Zhang L, et al: Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med. 10:950–958. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Gottfried E, Kreutz M, Haffner S, Holler E, Iacobelli M, Andreesen R and Eissner G: Differentiation of human tumour-associated dendritic cells into endothelial-like cells: An alternative pathway of tumour angiogenesis. Scand J Immunol. 65:329–335. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Berger S, Dyugovskaya L, Polyakov A and Lavie L: Short-term fibronectin treatment induces endothelial-like and angiogenic properties in monocyte-derived immature dendritic cells: Involvement of intracellular VEGF and MAPK regulation. Eur J Cell Biol. 91:640–653. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sozzani S, Rusnati M, Riboldi E, Mitola S and Presta M: Dendritic cell-endothelial cell cross-talk in angiogenesis. Trends Immunol. 28:385–392. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Osuka K, Usuda N, Aoyama M, Yamahata H, Takeuchi M, Yasuda M and Takayasu M: Expression of the JAK/STAT3/SOCS3 signaling pathway in herniated lumbar discs. Neurosci Lett. 569:55–58. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zang Y, Yu LF, Pang T, Fang LP, Feng X, Wen TQ, Nan FJ, Feng LY and Li J: AICAR induces astroglial differentiation of neural stem cells via activating the JAK/STAT3 pathway independently of AMP-activated protein kinase. J Biol Chem. 283:6201–6208. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Pennathur A, Gibson MK, Jobe BA and Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Montgomery EA, Basman FT, Brennan P and Malekzadeh R: Oesophageal Cancer. World Cancer Report 2014. Stewart BW and Wild CP: (Lyon). IARC Press. 374–382. 2014. | |
|
Wang XX, Wang K, Li XZ, Zhai LQ, Qu CX, Zhao Y, Liu ZR, Wang HZ, An QJ, Jing LW, et al: Targeted knockdown of IQGAP1 inhibits the progression of esophageal squamous cell carcinoma in vitro and in vivo. PLoS One. 9:e965012014. View Article : Google Scholar : PubMed/NCBI | |
|
Lu J, Zhao J, Liu K, Zhao J, Yang H, Huang Y, Qin Z, Bai R, Li P, Ma J, et al: MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma. Cell Mol Life Sci. 67:2091–2106. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Aranguren XL, Luttun A, Clavel C, Moreno C, Abizanda G, Barajas MA, Pelacho B, Uriz M, Araña M, Echavarri A, et al: In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells. Blood. 109:2634–2642. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Wu JC, Sheikh AY, Kraft D, Cao F, Xie X, Patel M, Gambhir SS, Robbins RC, Cooke JP, et al: Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation. 116(Suppl): I46–54. 2007.PubMed/NCBI | |
|
Lu J, Liu K, Zhao J, Zhao J, Ma J, Yang H, Huang Y, Qin Z, Bai R, Jiang L, et al: VEGF-A not Ang2 mediates endothelial-like differentiation of immature DCs by ERK1/2 signaling in the microenvironment of human colon adenocarcinoma. Int J Oncol. 38:1579–1588. 2011.PubMed/NCBI | |
|
Lu J, Zhao J, Zhao J, Ma J, Liu K, Yang H, Huang Y, Qin Z, Bai R, Li P, et al: VEGF-A-induced immature DCs not mature DCs differentiation into endothelial-like cells through ERK1/2-dependent pathway. Cell Biochem Funct. 29:294–302. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
El Deeb NM and Mehanna RA: Assessment of maturation status of tumor-infiltrating dendritic cells in invasive ductal carcinoma of the breast: Relation with vascular endothelial growth factor expression. Turk Patoloji Derg. 29:193–200. 2013.PubMed/NCBI | |
|
Zhao Y, Glesne D and Huberman E: A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA. 100:2426–2431. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Tang Y, Luo Y, Jiang Z, Lin CJ, Kim C, Carter MG, Amano T, Park J, Kish S, et al: Jak/Stat3 signaling promotes somatic cell reprogramming by epigenetic regulation. Stem Cells. 30:2645–2656. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Nefedova Y and Gabrilovich DI: Targeting of Jak/STAT pathway in antigen presenting cells in cancer. Curr Cancer Drug Targets. 7:71–77. 2007. View Article : Google Scholar : PubMed/NCBI |
